U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.682A>G (p.Thr228Ala) AND Monogenic diabetes

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Feb 28, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001248971.4

Allele description [Variation Report for NM_000162.5(GCK):c.682A>G (p.Thr228Ala)]

NM_000162.5(GCK):c.682A>G (p.Thr228Ala)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.682A>G (p.Thr228Ala)
Other names:
NM_000162.5(GCK):c.682A>G
HGVS:
  • NC_000007.14:g.44147831T>C
  • NG_008847.2:g.55340A>G
  • NM_000162.5:c.682A>GMANE SELECT
  • NM_001354800.1:c.682A>G
  • NM_033507.3:c.685A>G
  • NM_033508.3:c.679A>G
  • NP_000153.1:p.Thr228Ala
  • NP_001341729.1:p.Thr228Ala
  • NP_277042.1:p.Thr229Ala
  • NP_277043.1:p.Thr227Ala
  • LRG_1074t1:c.682A>G
  • LRG_1074t2:c.685A>G
  • LRG_1074:g.55340A>G
  • LRG_1074p1:p.Thr228Ala
  • LRG_1074p2:p.Thr229Ala
  • NC_000007.13:g.44187430T>C
  • NC_000007.13:g.44187430T>C
  • NM_000162.3:c.682A>G
  • NM_000162.4(GCK):c.682A>G
  • p.THR228ALA
  • p.Thr228Ala
Protein change:
T227A
Links:
dbSNP: rs1332966015
NCBI 1000 Genomes Browser:
rs1332966015
Molecular consequence:
  • NM_000162.5:c.682A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.682A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.685A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.679A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Monogenic diabetes
Identifiers:
MONDO: MONDO:0015967; MedGen: C3888631

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001422803Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 22, 2020)
germlinecuration

PubMed (6)
[See all records that cite these PMIDs]

Citation Link,

SCV004697917ClinGen Monogenic Diabetes Variant Curation Expert Panel
reviewed by expert panel

(ClinGen Monogenic Diabetes ACMG Specifications GCK V1.3.0)
Pathogenic
(Feb 28, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young.

Mantovani V, Salardi S, Cerreta V, Bastia D, Cenci M, Ragni L, Zucchini S, Parente R, Cicognani A.

Hum Mutat. 2003 Oct;22(4):338.

PubMed [citation]
PMID:
12955723

Identification and characterization of the ATP-binding site in human pancreatic glucokinase.

Marotta DE, Anand GR, Anderson TA, Miller SP, Okar DA, Levitt DG, Lange AJ.

Arch Biochem Biophys. 2005 Apr 1;436(1):23-31.

PubMed [citation]
PMID:
15752705
See all PubMed Citations (6)

Details of each submission

From Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, SCV001422803.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (6)

Description

The p.Thr228Ala variant in GCK has been reported in 3 Italian individuals with Monogenic Diabetes, segregated with disease in these 3 affected relatives from 1 family (PMID: 12955723), and has been identified in 0.005442% (1/18374) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported likely pathogenic in ClinVar (Variation ID: 447413). In vitro functional studies provide some evidence that the p.Thr228Ala variant may impact ATP binding (PMID: 15752705, 15102714, 19790256). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. One pathogenic variant with a different amino acid change at the same position, p.Thr228Met, has been reported in association with disease in ClinVar, supporting that a change at this position may not be tolerated (Variation ID: 16134). Multiple variants in the same region as p.Thr228Ala have been reported in association with disease in ClinVar and the literature, suggesting that this variant is in an important functional domain and slightly supports pathogenicity (PMID: 22389783; Variation ID: 36244, 36243, 546098). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PS3_moderate, PM5, PM2_Supporting, PP3, PM1_Supporting, PP1 (Richards 2015).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ClinGen Monogenic Diabetes Variant Curation Expert Panel, SCV004697917.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.682A>G variant in the glucokinase gene, GCK, causes an amino acid change of threonine to alanine at codon 228 (p.(Thr228Ala)) of NM_000162.5. GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.931 which is greater than the MDEP VCEP threshold of 0.70 (PP3). This variant resides in an amino acid that directly binds ATP, which is defined as critical for the protein's function by the ClinGen MDEP (PM1). This variant has an incomputable gnomAD v2.1.1 Grpmax filtering allele frequency due to 1 copy in the East Asian subpopulation and no copies in any other subpopulation, thereby meeting the ClinGen MDEP threshold criteria for PM2_Supporting (ENF Popmax FAF <= 0.000003 and <= 2 copies in ENF and <=1 copy in any other subpopulation) (PM2_Supporting). This variant was identified in 7 unrelated individuals with hyperglycemia (PS4, PMIDs: 31638168, 12955723, internal lab contributors). Another missense variant, c.683C>T p.Thr228Met, has been classified as pathogenic by the ClinGen MDEP but has a greater Grantham distance than p.Thr228Ala (PM5_Supporting). In summary, c.682A>G meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3, approved 8/11/2023): PM1, PP2, PP3, PM2_Supporting, PM5_Supporting, PS4.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024